Diversified (DHC) | Financial Analysis & Statements
Diversified Healthcare Trust Small-cap Real Estate
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Dec 2025Income Metrics
Revenue
379.6M
Gross Profit
72.5M
19.11%
Operating Income
-2.0M
-0.53%
Net Income
-21.2M
-5.59%
Balance Sheet Metrics
Total Assets
4.4B
Total Liabilities
2.7B
Shareholders Equity
1.7B
Debt to Equity
1.62
Cash Flow Metrics
Operating Cash Flow
62.5M
Free Cash Flow
-20.1M
Revenue & Profitability Trend
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Diversified Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 1.5B | 1.5B | 1.4B | 1.3B | 1.4B |
| Cost of Goods Sold | 1.3B | 1.2B | 1.2B | 1.1B | 1.1B |
| Gross Profit | 278.5M | 258.9M | 236.2M | 174.5M | 291.4M |
| Gross Margin % | 18.1% | 17.3% | 16.7% | 13.6% | 21.1% |
| Operating Expenses | |||||
| Research & Development | - | - | - | - | - |
| Selling, General & Administrative | 45.5M | 26.5M | 26.1M | 26.4M | 34.1M |
| Other Operating Expenses | - | - | - | - | - |
| Total Operating Expenses | 45.5M | 26.5M | 26.1M | 26.4M | 34.1M |
| Operating Income | -28.9M | -52.6M | -74.1M | -91.2M | -13.8M |
| Operating Margin % | -1.9% | -3.5% | -5.3% | -7.1% | -1.0% |
| Non-Operating Items | |||||
| Interest Income | 5.8M | 9.0M | 15.5M | 15.9M | 20.6M |
| Interest Expense | 204.5M | 235.2M | 191.8M | 209.4M | 255.8M |
| Other Non-Operating Income | -93.3M | -92.5M | -22.4M | 263.6M | 430.3M |
| Pre-tax Income | -320.9M | -371.4M | -272.7M | -21.1M | 181.4M |
| Income Tax | 1.7M | 467.0K | 445.0K | 710.0K | 1.4M |
| Effective Tax Rate % | 0.0% | 0.0% | 0.0% | 0.0% | 0.8% |
| Net Income | -285.9M | -370.3M | -293.6M | -15.8M | 179.9M |
| Net Margin % | -18.6% | -24.8% | -20.8% | -1.2% | 13.0% |
| Key Metrics | |||||
| EBITDA | 239.0M | 241.4M | 225.6M | 164.2M | 277.9M |
| EPS (Basic) | $-1.19 | $-1.55 | $-1.23 | $-0.07 | $0.73 |
| EPS (Diluted) | $-1.19 | $-1.55 | $-1.23 | $-0.07 | $0.73 |
| Basic Shares Outstanding | 240286000 | 239535000 | 238836000 | 238314000 | 237967000 |
| Diluted Shares Outstanding | 240286000 | 239535000 | 238836000 | 238314000 | 237967000 |
Income Statement Trend
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Diversified Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 105.4M | 144.6M | 245.9M | 658.1M | 634.8M |
| Short-term Investments | - | - | - | - | - |
| Accounts Receivable | - | - | - | - | - |
| Inventory | - | - | - | - | - |
| Other Current Assets | - | - | - | - | - |
| Total Current Assets | 148.9M | 430.2M | 262.5M | 697.4M | 1.0B |
| Non-Current Assets | |||||
| Property, Plant & Equipment | - | - | - | - | - |
| Goodwill | 20.7M | 26.3M | 33.9M | 45.4M | 48.7M |
| Intangible Assets | - | - | - | - | - |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 185.5M | 188.6M | 222.2M | 233.8M | 235.4M |
| Total Non-Current Assets | 4.2B | 4.7B | 5.2B | 5.3B | 5.6B |
| Total Assets | 4.4B | 5.1B | 5.4B | 6.0B | 6.6B |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | - | - | - | - | - |
| Short-term Debt | - | - | - | 700.0M | 800.0M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | 3.4M | 6.0M | 32.0K | - | - |
| Total Current Liabilities | 56.8M | 38.1M | 29.9M | 734.6M | 838.1M |
| Non-Current Liabilities | |||||
| Long-term Debt | 2.4B | 2.9B | 2.8B | 2.3B | 2.9B |
| Deferred Tax Liabilities | - | - | - | - | - |
| Other Non-Current Liabilities | 238.0M | 229.2M | 262.5M | 281.0M | 246.5M |
| Total Non-Current Liabilities | 2.6B | 3.1B | 3.1B | 2.6B | 3.1B |
| Total Liabilities | 2.7B | 3.2B | 3.1B | 3.4B | 4.0B |
| Equity | |||||
| Common Stock | 2.4M | 2.4M | 2.4M | 2.4M | 2.4M |
| Retained Earnings | -3.0B | -2.7B | -2.3B | -2.0B | -2.0B |
| Treasury Stock | - | - | - | - | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 1.7B | 2.0B | 2.3B | 2.6B | 2.7B |
| Key Metrics | |||||
| Total Debt | 2.4B | 2.9B | 2.8B | 3.0B | 3.7B |
| Working Capital | 92.0M | 392.1M | 232.5M | -37.2M | 178.8M |
Balance Sheet Composition
Diversified Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | -285.9M | -370.3M | -293.6M | -15.8M | 179.9M |
| Depreciation & Amortization | 262.0M | 285.1M | 283.8M | 239.5M | 263.9M |
| Stock-Based Compensation | - | - | - | - | - |
| Working Capital Changes | 25.7M | 6.6M | -21.3M | 2.1M | -72.8M |
| Operating Cash Flow | 70.9M | 22.3M | -20.0M | 223.5M | 376.8M |
| Investing Activities | |||||
| Capital Expenditures | - | - | - | - | - |
| Acquisitions | -8.5M | -21.2M | 0 | 108.4M | 367.0M |
| Investment Purchases | - | - | - | - | - |
| Investment Sales | - | - | - | - | 0 |
| Investing Cash Flow | -7.2M | -19.5M | 14.5M | 122.9M | 367.0M |
| Financing Activities | |||||
| Share Repurchases | -1.1M | -904.0K | -393.0K | -171.0K | -383.0K |
| Dividends Paid | -9.7M | -9.6M | -9.6M | -9.6M | -9.5M |
| Debt Issuance | 712.5M | 120.0M | 750.0M | 0 | 492.5M |
| Debt Repayment | -1.1B | -123.2M | -967.0M | -639.1M | -503.2M |
| Financing Cash Flow | -492.0M | -22.3M | -949.7M | -776.0M | 746.7M |
| Free Cash Flow | -19.6M | 112.2M | 10.5M | -40.4M | -63.3M |
| Net Change in Cash | -428.3M | -19.4M | -955.2M | -429.6M | 1.5B |
Cash Flow Trend
Diversified Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
-6.26
Forward P/E
-16.76
Price to Book
1.08
Price to Sales
1.17
PEG Ratio
-16.76
Profitability Ratios
Profit Margin
-18.59%
Operating Margin
-2.93%
Return on Equity
-15.78%
Return on Assets
-0.52%
Financial Health
Current Ratio
6.08
Debt to Equity
145.16
Beta
2.34
Per Share Data
EPS (TTM)
$-1.19
Book Value per Share
$6.88
Revenue per Share
$6.40
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| DHC | 1.8B | -6.26 | 1.08 | -15.78% | -18.59% | 145.16 |
| Welltower | 147.1B | 146.65 | 3.44 | 2.54% | 8.64% | 49.49 |
| Ventas | 39.8B | 153.57 | 3.14 | 2.17% | 4.32% | 102.00 |
| LTC Properties | 1.9B | 15.36 | 1.97 | 11.18% | 45.79% | 85.30 |
| Sila Realty Trust | 1.7B | 50.67 | 1.25 | 2.42% | 16.77% | 54.02 |
| Global Medical REIT | 956.6M | - | 1.18 | 0.41% | 1.73% | 142.96 |
Financial data is updated regularly. All figures are in the company's reporting currency.






